Read Newmanbrain latest blog publications.
Pablo Belmonte, Newmanbrain CEO, shares a discussion table in the edition of “SOFTING TIC&TALK” of ITI that is held in Alicante.
MCI or Mild Cognitive Impairment, is a condition in which patients experiment a cognitive decline
We are thrilled to announce that our latest fNIRs device, THEIA™, has been awarded an iF Design Award 2023.
Last week, Newmanbrain participated in the 100 Startups Health event at La Nave in Madrid.
Last Friday March 3rd, Newmanbrain participated in the event “AI Applied to the Hospital Management”
Newmanbrain was awarded in the IV edition of the rePCV (Valencian Community Scientific Parks network)